Introduction {#sec1_1}
============

Central pontine myelinolysis (CPM) was first described in 1959 by Adams \[[@B2]\] in patients with a history of alcohol abuse. It has been classically defined as a symmetrical and selective destruction of myelin sheaths in the central portion of the basis pontis, without evidence of an underlying vascular lesion or signs of inflammation detectable on MRI.

In the clinical setting, CPM has been reported mainly in association with rapid correction of hyponatremia, but also in other medical conditions, such as hypernatremia, hypokalemia, the syndrome of inappropriate antidiuretic hormone hypersecretion (SIADH), liver and renal transplantation, severe liver disease, chronic alcoholism, malnutrition, anorexia nervosa and hyperemesis gravidarum. It has also been reported in association with Wernike\'s encephalopathy, Wilson\'s disease, brain tumors, brain edema, adrenal insufficiency, carcinoma and Hodgkin\'s disease, chemotherapy, HIV infection, immunosuppression and autoimmune mechanisms. It has frequently been reported autoptically in asymptomatic patients \[[@B3], [@B4]\].

Clinical features include mental status changes, quadriparesis, pseudobulbar palsy, whereas cerebellar ataxia is an extremely unusual sign in CPM. We report a case of ataxia in CPM with a complete clinical and radiological recovery.

Case Report {#sec1_2}
===========

A right-handed 74-year-old man was admitted to our hospital in May 2007 for gait disturbances for 2 days. There was no prior history of any neurological disorder. The patient underwent partial colectomy for a sigma colon cancer with lung metastasis, and he received chemotherapy with 5-fluorouracil and oxaliplatin. Neurological examination showed a significant truncal and limb ataxia with bilateral intention tremor. Cranial nerve function was normal, nystagmus was absent, power and sensory function in all 4 limbs as well as deep tendon reflexes were normal, and plantar responses were flexor bilaterally. Brain MRI with gadolinium showed some central pontine lesions without significant mass effect or contrast enhancement consistent with CPM. There were no other abnormalities in the rest of the brain (fig. [1](#F1){ref-type="fig"}). Several blood tests showed mild neutropenia, low serum levels of total cholesterol and albumin, but no evidence of electrolyte abnormalities (sodium: 138 mEq/l, potassium: 3.7 mEq/l, calcium: 9.3 mg/dl, phosphorus: 4.50 mg/dl, bicarbonate: 35 mEq/l, magnesium: 1.9 mg/dl). The patient gradually improved without any specific treatment, and after 1 month, the neurological picture was back to normal. Moreover, a second brain MRI with gadolinium carried out 2 months later was unremarkable (fig. [2](#F2){ref-type="fig"}).

Discussion {#sec1_3}
==========

CPM is an uncommon demyelinating disorder of unknown etiology. The mechanism of CPM is not well understood. Although in the original description of CPM by Adams there was no mention of electrolyte unbalance, it has become clear that osmotic balance is correlated to CPM in most cases. The factors implicated in CPM include alcohol abuse, malnutrition, diseases (such as chronic debilitation, cerebral ischemia, impaired fat metabolism, and infections), individual predisposition, dehydration, osmolarity fluctuations, liver dysfunction, SIADH, and prolonged diuretic use.

Histologic studies have shown that oligodendrocytes are susceptible to CPM-related osmotic stress, especially making high-density brain areas, such as the central pons, thalamus, cortex, putamen, lateral geniculate, and other extrapontine sites, vulnerable to this mechanism \[[@B1]\]. The neurons and axons are typically preserved, unlike in central pontine infections. There is no inflammatory reaction associated with osmotic demyelination, differentiating this process from multiple sclerosis, which is characterized by marked perivascular inflammation. In several reports, CPM is well described as a complication of chronic hyponatremia correction, especially when the correction occurs rapidly. Therefore, CPM is also known as osmotic demyelination syndrome, caused by release of toxic compounds \[[@B1], [@B2], [@B3], [@B4]\].

In a recent case report, severe CPM accompanied by unusual extensive extrapontine myelinolysis was described in a chronic alcohol abuser without hyponatremia. The patient underwent methylprednisolone pulse therapy. After 7 weeks\' serial follow-up, MRI revealed a complete resolution of extrapontine myelinolysis, but the pons lesions remained unchanged \[[@B5]\]. In the present case, there was no evidence of electrolyte abnormalities. Furthermore, the clinical setting gradually improved without any treatment, and after 1 month the neurological picture was back to normal.

Although we cannot rule out that our patient had suffered from minor fluctuations in serum sodium levels between the measurements, our patient presented with no evidence of hyponatremia based on the available data. On the other hand, the MRI abnormality is unlikely to be vascular in nature given the normal diffusion-weighted imaging sequences.

Our case of CPM occurred in a patient with colon cancer metastasized to the lungs. Previously, another case of lung carcinoma and CPM was reported, but associated with SIADH \[[@B6]\]. CPM was also observed in 2 cases of nasopharyngeal carcinoma after cisplatin chemotherapy. This treatment is increasingly used in advanced head and neck cancers, and hyponatremia -- usually regarded as a mild entity -- is a common therapy complication \[[@B11]\]. Our patient did not develop hyponatremia after chemotherapy. Moreover, in our case, cerebellar symptoms were the main clinical findings. Cerebellar ataxia as the prevalent clinical sign of CPM is extremely rare, and it was only described in isolated reports (table [1](#T1){ref-type="table"}) \[[@B7], [@B8], [@B9], [@B10], [@B11], [@B12], [@B13], [@B14]\].

As in our patient, in all other cases of CPM with cerebellar ataxia, brain MRI with gadolinium revealed the presence of central pontine lesions, whereas a frontal atrophy and a moderate cerebellar atrophy were observed only in 1 case \[[@B13]\]. This neurological disorder is increasingly recognized, especially due to MRI, which shows the typical findings in the central pons: hypointense lesions in sagittal T1-weighted images and a triangular area hyperintense on axial T2-weighted images.

In conclusion, in the literature, only 1 case of CPM with cerebellar ataxia in association with malignancy is reported; however, unlike our case, this patient presented with SIADH and underwent correction of hyponatremia after chemotherapy \[[@B14]\]. The cause of myelinolysis remains under debate, and although osmotic effects seem to be responsible in most patients, the role of malignancy should be considered because it may be more common than the literature suggest.

This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License ([www.karger.com/OA-license](http//www.karger.com/OA-license)), applicable to the online version of the article only. Distribution for non-commercial purposes only.

![Brain MRI with gadolinium proved the presence of central pontine lesions without significant mass effect.](crn0002-0157-f01){#F1}

![The brain MRI in T2 flair showed the resolution of the central pontine lesions.](crn0002-0157-f02){#F2}

###### 

Cases of CPM with ataxia

  Reference                             Case   Clinical picture                                        Alcoholism/malnutrition   Electrolyte disturbance        Cancers                                Paraneo-plastic syndromes   Treatments                                     Chemotherapy                  Outcome                         MRI follow-up
  ------------------------------------- ------ ------------------------------------------------------- ------------------------- ------------------------------ -------------------------------------- --------------------------- ---------------------------------------------- ----------------------------- ------------------------------- ------------------------------------------
  Defebre et al., 1995 \[[@B7]\]        2      ataxia, intention tremor, dysarthria                    yes/no                    hyponatremia, hypokalemia      no                                     no                          hyponatremia correction                        no                            neurological sequelae           CPM EPM[^1^](#T1F1){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                
  Gille et al., 1993 \[[@B8]\]          1      ataxia, intention tremor, hypotonia, dysarthria         yes/no                    hyponatremia, hypokalemia      no                                     no                          hyponatremia correction                        no                            alcoholic dementia              CPM EPM[^2^](#T1F2){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                
  Steller et al., 1988 \[[@B9]\]        1      ataxia, intention tremor, hypotonia, dysarthria         yes/no                    hyponatremia, hypokalemia      no                                     no                          hyponatremia correction                        no                            no neurological sequelae        CPM EPM[^1^](#T1F1){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                
  Rajbhandari et al., 1998 \[[@B10]\]   1      ataxia, intention tremor, hypotonia, dysarthria         yes/no                    hyponatremia, hypokalemia      no                                     no                          hyponatremia correction                        no                            no neurological sequelae        CPM EPM[^1^](#T1F1){ref-type="table-fn"}
                                                                                                                                                                                                                                                                                                                                                
  Menger and Jörg, 1999 \[[@B11]\]      2      ataxia                                                  yes/no                    Hyponatremia                   no                                     no                          hyponatremia correction, methyl-prednisolone   no                            severe ataxia for 4--7 months   CPM
                                                                                                                                                                                                                                                                                                                                                
  Hagiwara et al., 2008 \[[@B12]\]      1      ataxia, pyramidal spasticity, extrapyramidal rigidity   yes/no                    no electrolyte abnormalities   no                                     no                          methyl-prednisolone                            no                            no neurological sequelae        CPM (resolution EPM)
                                                                                                                                                                                                                                                                                                                                                
  Garzon et al., 2002 \[[@B13]\]        1      ataxia                                                  yes/no                    no electrolyte abnormalities   no                                     no                          no                                             no                            no neurological sequelae        CPM
                                                                                                                                                                                                                                                                                                                                                
  Yau et al., 1993 \[[@B14]\]           1      ataxia, dysphagia, dysarthria                           no/no                     hyponatremia                   yes[^3^](#T1F3){ref-type="table-fn"}   SIADH                       hyponatremia correction                        cisplatine                    no neurological sequelae        CPM
                                                                                                                                                                                                                                                                                                                                                
  Present case report                   1      ataxia, intention tremor                                no/no                     no electrolyte abnormalities   yes[^4^](#T1F4){ref-type="table-fn"}   no                          no                                             5-fluorouracil, oxaliplatin   no neurological sequelae        recovery

Cerebellar peduncles.

Cerebellar peduncles; mild cerebellar atrophy.

Nasopharyngeal carcinoma.

Sigma-colon cancer. EPM = Extrapontine myelinolysis.
